Skip to main content
Log in

Dedicated system for COVID-19 vaccine safety surveillance at Lareb

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Oosterhuis I, et al. Optimizing Safety Surveillance for COVID-19 Vaccines at the National Pharmacovigilance Centre Lareb: One Year of COVID-19 Vaccine Experience Drug Safety : 16 Nov 2022. Available from: URL: https://doi.org/10.1007/s40264-022-01253-5

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dedicated system for COVID-19 vaccine safety surveillance at Lareb. Reactions Weekly 1934, 7 (2022). https://doi.org/10.1007/s40278-022-28388-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-28388-x

Navigation